It is rare for a person who has completed a 5-year medical and research program with a focus on molecular genetics to develop an abiding interest in investing, rarer still for that person to make a highly successful career of it (although Michael Burry might be an exception here).
Yet, Dr. Ken Shubin Stein, Founder and Portfolio Manager of Spencer Capital Management and Chairman of Spencer Capital Holdings, made the transition from medicine to value investing with ease.
“Something we try to do well is...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
